Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.6 USD | -4.14% |
|
+2.81% | +38.52% |
Jun. 24 | Avalo Therapeutics Names Chief Legal Officer | MT |
Jun. 24 | Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.52% | 13.6M | |
+17.71% | 44.63B | |
+43.40% | 40.46B | |
-8.99% | 38.07B | |
+33.31% | 32.27B | |
-8.98% | 27.3B | |
+14.61% | 26.53B | |
+45.44% | 14.06B | |
+32.54% | 12.54B | |
-8.71% | 11.28B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Cerecor Inc. Provides Revenue Guidance for the Year 2019